Suryaa National Desk: Researchers have reached a milestone in the study of early-onset Parkinson's disease. A recent study reveals that specific changes occurring in blood platelets can be used to identify the progression of the disease at an early stage.
While Parkinson's disease is typically associated with the impact on nerve cells in the brain, this study indicates that biological changes in the structure of platelets, which assist in blood clotting, are directly linked to the condition. By examining blood samples, scientists observed distinct differences in platelet behavior as the disease progressed. These biomarkers allow for the assessment of the disease with high accuracy.
Medical experts suggest that this discovery will be useful in detecting neurological disorders in their initial stages. As brain cells are often significantly damaged by the time symptoms become fully apparent, this blood testing method provides a new tool for medical professionals. It is expected that these findings will assist in providing improved and personalized treatment for Parkinson's patients in the future.
